NeuroVasc Technologies

NeuroVasc Technologies is a private company dedicated to advancing neurovascular innovation.

NeuroVasc Technologies focuses on novel catheter-based technologies to treat neurovascular disease.

NeuroVasc Technologies was founded in 2015 and is headquartered in Irvine, California.

 

NeuroVasc has developed a comprehensive portfolio development strategy to bring differentiated tools to the INR community to facilitate broader treatment options for patients suffering stroke and other neurovascular diseases.

NeuroVasc’s efforts are not just to develop a single product or single family of products, but to assemble a leading catalogue of products—internally developed and acquired—to address unmet needs in the treatment of neurovascular disease.

NeuroVasc Technologies' current core product is a next-generation mechanical thrombectomy system that is designed to improve physicians’ clot retrieval capabilities in tortuous anatomy. NeuroVasc has received a CE Mark and is commercially active in Europe and Hong Kong, with 2020 commercial sales activity planned to expand into South America and Southeast Asia.

 

NeuroVasc Technologies is backed by Wego Group and others. The company raised $34M in a latest financing on Feb 27, 2020. This brings NeuroVasc's total funding to $42.8M to date.

 

 

  • Year founded: 2015
  • Funding Info: $42.5M over 3 Rounds (Latest Funding Type: Venture- Series Unknown)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Irvine
  • State: California
  • Country: United States
Related businesses